Condition
Diabetic Cardiomyopathy
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 4 (1)
Trial Status
Unknown2
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06593327Not ApplicableRecruiting
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
NCT05102851CompletedPrimary
Impact of Prediabetes on Acute Coronary Syndrome
NCT01803828Phase 4CompletedPrimary
REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs
NCT03904485Unknown
Assessment of Myocardial Injury in Simultaneous Pancreas and Kidney Transplantation
NCT00628056Phase 1UnknownPrimary
Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes
Showing all 5 trials